Search alternatives:
linear decrease » linear increase (Expand Search)
lower decrease » larger decrease (Expand Search), we decrease (Expand Search), showed decreased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
Showing 1,321 - 1,340 results of 4,639 for search 'significantly ((((lower decrease) OR (teer decrease))) OR (linear decrease))', query time: 0.32s Refine Results
  1. 1321
    Non-linear associations between serum manganese with chronic kidney disease: results from two nationwide studies in the United States and China

    Non-linear associations between serum manganese with chronic kidney disease: results from two nationwide studies in the United States and China by Jiliang Zhang (1500367)

    Published 2025
    “…</p> <p>The higher Mn concentration was significantly associated with a lower prevalence of CKD through different non-linear patterns.…”
    Save to List
    Saved in:
  2. 1322
    Fig 1 - Fusing multisensory signals across channels and time

    Fig 1 - Fusing multisensory signals across channels and time by Swathi Anil (17382903)

    Published 2025
    Save to List
    Saved in:
  3. 1323
    Data Sheet 1_Exploring the glucose-lowering and anti-inflammatory immune mechanism of artemether by AMPK/mTOR pathway and microbiome based on multi-omics.docx

    Data Sheet 1_Exploring the glucose-lowering and anti-inflammatory immune mechanism of artemether by AMPK/mTOR pathway and microbiome based on multi-omics.docx by Tao Jiang (28401)

    Published 2025
    Save to List
    Saved in:
  4. 1324
    Image1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  5. 1325
    Image2_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image2_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  6. 1326
    Image8_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image8_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  7. 1327
    Image5_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image5_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  8. 1328
    Image6_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image6_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  9. 1329
    Image3_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image3_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  10. 1330
    Image4_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image4_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  11. 1331
    Image7_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF

    Image7_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”
    Save to List
    Saved in:
  12. 1332
    Joint Efficiency (%) of ABS Polymers at 800 rpm and 1200 rpm.

    Joint Efficiency (%) of ABS Polymers at 800 rpm and 1200 rpm. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1333
    Schematic of fixture.

    Schematic of fixture. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1334
    Average shore hardness values of ABS and PC welded samples.

    Average shore hardness values of ABS and PC welded samples. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1335
    Fabricated Fixture with labelled view.

    Fabricated Fixture with labelled view. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1336
    Joint Efficiency (%) of PC Polymers at 800 rpm and 1200 rpm.

    Joint Efficiency (%) of PC Polymers at 800 rpm and 1200 rpm. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1337
    Tensile Strength (MPa) of PC Polymers at 800 rpm and 1200 rpm.

    Tensile Strength (MPa) of PC Polymers at 800 rpm and 1200 rpm. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1338
    Experimentation plan.

    Experimentation plan. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1339
    Experimental details.

    Experimental details. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1340
    Maximum Axial Force values of ABS Polymers at 800 and 1200 rpm.

    Maximum Axial Force values of ABS Polymers at 800 and 1200 rpm. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: